Krsnaa Diagnostics Ltd.
•₹ 561.652.12%
2026-08-21
PROS
- Strong cash generation - operating cash flow backs reported profits (CFO/PAT 0.96x)
- Working capital cycle has improved - days down from 82 to 56
- Company maintains a comfortable, low leverage position
CONS
- Receivables are growing faster than sales - a possible quality concern
- Company has a low return on equity of 8.4% over last 3 years
- Company has a low return on capital employed of 11.4%
- Free cash flow has been persistently negative
- Operating margins have contracted to 26.5% from 32.1%
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | APOLLOHOSP | 8799.00 | 60.55 | 126516.12 | 0.23 | 610.40 | 38.41 | 7043.50 | 20.56 | 21.73 | 15.70 |
| 2. | MANIPALHOS | 744.55 | 109.75 | 97936.41 | 0.00 | — | — | — | — | 13.93 | — |
| 3. | MAXHEALTH | 996.45 | 66.57 | 96982.14 | 0.20 | 322.96 | 4.87 | 2366.17 | 16.70 | 14.97 | 25.29 |
| 4. | ASTERDM | 800.70 | 219.01 | 69794.81 | 0.00 | 29.28 | -68.70 | 1310.68 | 21.60 | 11.46 | 19.53 |
| 5. | FORTIS | 910.80 | 65.62 | 68761.59 | 0.11 | 272.80 | 2.26 | 2545.03 | 17.46 | 14.07 | 21.28 |
| 6. | MEDANTA | 1419.05 | 68.60 | 38154.25 | 0.04 | 157.25 | -1.09 | 1304.05 | 26.50 | 20.50 | 21.99 |
| 7. | NH | 1782.70 | 44.64 | 36431.40 | 0.25 | 207.27 | 5.37 | 2683.63 | 78.05 | 16.20 | 17.43 |
| 8. | KIMS | 788.60 | 162.12 | 33121.71 | 0.00 | 37.40 | -56.00 | 1179.50 | 35.33 | 11.51 | 19.03 |
| 9. | LALPATHLAB | 1886.80 | 58.44 | 31669.72 | 1.09 | 1705.00 | 1172.39 | 7977.00 | 1090.95 | 29.56 | 31.03 |
| 10. | AGARWALEYE | 499.70 | 106.77 | 15841.80 | 0.00 | 55.02 | 44.56 | 614.02 | 25.97 | 14.32 | 27.75 |
| 11. | VIJAYA | 1489.70 | 81.84 | 15343.57 | 0.13 | 53.10 | 37.61 | 230.98 | 22.83 | 30.27 | 42.66 |
| 12. | KRSNAA | 537.35 | 17.89 | 1743.09 | 0.37 | 16.55 | -19.34 | 235.53 | 22.05 | 12.39 | 24.62 |
Detailed Comparison with:
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 140 | 155 | 158 | 166 | 170 | 186 | 175 | 186 | 193 | 206 | 181 | 193 | 236 | |
| 108 | 124 | 121 | 123 | 128 | 137 | 129 | 133 | 142 | 147 | 135 | 138 | 220 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 4 | 4 | 4 | 4 | 7 | 5 | 9 | 4 | 4 | 4 | 4 | 32 | 7 |
| Interest | 2 | 3 | 4 | 7 | 5 | 6 | 6 | 7 | 6 | 8 | 8 | 12 | 15 |
| Depreciation | 16 | 19 | 21 | 18 | 21 | 22 | 23 | 22 | 22 | 24 | 23 | 23 | 28 |
| 18 | 13 | 16 | 23 | 23 | 25 | 25 | 29 | 27 | 32 | 20 | 52 | 22 | |
| Tax % | 18.17% | 21.76% | 19.38% | 17.16% | 22.76% | 22.87% | 23.78% | 27.72% | 25.17% | 24.15% | 22.46% | 19.30% | 26.23% |
| Net Profit | 0 | 0 | 0 | 0 | 18 | 20 | 19 | 21 | 21 | 24 | 15 | 42 | 17 |
| 5 | 3 | 4 | 6 | 6 | 6 | 6 | 6 | 6 | 7 | 5 | 13 | 1 | |
| Equity Capital | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Jun 2023
- 140
- 108
- Operating Profit
- —
- OPM %
- —
- Other Income
- 4
- Interest
- 2
- Depreciation
- 16
- 18
- Tax %
- 18.17%
- Net Profit
- 0
- 5
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2023
- 155
- 124
- Operating Profit
- —
- OPM %
- —
- Other Income
- 4
- Interest
- 3
- Depreciation
- 19
- 13
- Tax %
- 21.76%
- Net Profit
- 0
- 3
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 158
- 121
- Operating Profit
- —
- OPM %
- —
- Other Income
- 4
- Interest
- 4
- Depreciation
- 21
- 16
- Tax %
- 19.38%
- Net Profit
- 0
- 4
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 166
- 123
- Operating Profit
- —
- OPM %
- —
- Other Income
- 4
- Interest
- 7
- Depreciation
- 18
- 23
- Tax %
- 17.16%
- Net Profit
- 0
- 6
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 170
- 128
- Operating Profit
- —
- OPM %
- —
- Other Income
- 7
- Interest
- 5
- Depreciation
- 21
- 23
- Tax %
- 22.76%
- Net Profit
- 18
- 6
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 186
- 137
- Operating Profit
- —
- OPM %
- —
- Other Income
- 5
- Interest
- 6
- Depreciation
- 22
- 25
- Tax %
- 22.87%
- Net Profit
- 20
- 6
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 175
- 129
- Operating Profit
- —
- OPM %
- —
- Other Income
- 9
- Interest
- 6
- Depreciation
- 23
- 25
- Tax %
- 23.78%
- Net Profit
- 19
- 6
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 186
- 133
- Operating Profit
- —
- OPM %
- —
- Other Income
- 4
- Interest
- 7
- Depreciation
- 22
- 29
- Tax %
- 27.72%
- Net Profit
- 21
- 6
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 193
- 142
- Operating Profit
- —
- OPM %
- —
- Other Income
- 4
- Interest
- 6
- Depreciation
- 22
- 27
- Tax %
- 25.17%
- Net Profit
- 21
- 6
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 206
- 147
- Operating Profit
- —
- OPM %
- —
- Other Income
- 4
- Interest
- 8
- Depreciation
- 24
- 32
- Tax %
- 24.15%
- Net Profit
- 24
- 7
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 181
- 135
- Operating Profit
- —
- OPM %
- —
- Other Income
- 4
- Interest
- 8
- Depreciation
- 23
- 20
- Tax %
- 22.46%
- Net Profit
- 15
- 5
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 193
- 138
- Operating Profit
- —
- OPM %
- —
- Other Income
- 32
- Interest
- 12
- Depreciation
- 23
- 52
- Tax %
- 19.30%
- Net Profit
- 42
- 13
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 236
- 220
- Operating Profit
- —
- OPM %
- —
- Other Income
- 7
- Interest
- 15
- Depreciation
- 28
- 22
- Tax %
- 26.23%
- Net Profit
- 17
- 1
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|
| 455 | 487 | 620 | 717 | 815 | |
| 324 | 365 | 475 | 527 | 640 | |
| Operating Profit | 146 | 142 | 161 | 216 | — |
| OPM % | 32 | 29 | 26 | 30 | — |
| Other Income | 15 | 19 | 17 | 26 | 47 |
| Interest | 18 | 8 | 16 | 25 | 43 |
| Depreciation | 41 | 54 | 75 | 88 | 97 |
| 87 | 80 | 70 | 103 | 125 | |
| Tax % | 21 | 23 | 19 | 24 | 22 |
| Net Profit | 68 | 62 | 57 | 78 | 98 |
| EPS | 23 | 19 | 18 | 24 | — |
| Dividend Payout % | 11 | 14 | 14 | 11 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | -0 |
| Adjusted EPS | 22 | 20 | 18 | 24 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | -0 |
| Adjusted EPS | 22 | 20 | 18 | 24 | — |
Mar 2022
- 455
- 324
- Operating Profit
- 146
- OPM %
- 32
- Other Income
- 15
- Interest
- 18
- Depreciation
- 41
- 87
- Tax %
- 21
- Net Profit
- 68
- EPS
- 23
- Dividend Payout %
- 11
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 22
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 22
Mar 2023
- 487
- 365
- Operating Profit
- 142
- OPM %
- 29
- Other Income
- 19
- Interest
- 8
- Depreciation
- 54
- 80
- Tax %
- 23
- Net Profit
- 62
- EPS
- 19
- Dividend Payout %
- 14
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 20
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 20
Mar 2024
- 620
- 475
- Operating Profit
- 161
- OPM %
- 26
- Other Income
- 17
- Interest
- 16
- Depreciation
- 75
- 70
- Tax %
- 19
- Net Profit
- 57
- EPS
- 18
- Dividend Payout %
- 14
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 18
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 18
Mar 2025
- 717
- 527
- Operating Profit
- 216
- OPM %
- 30
- Other Income
- 26
- Interest
- 25
- Depreciation
- 88
- 103
- Tax %
- 24
- Net Profit
- 78
- EPS
- 24
- Dividend Payout %
- 11
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 24
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 24
TTM
- 815
- 640
- Operating Profit
- —
- OPM %
- —
- Other Income
- 47
- Interest
- 43
- Depreciation
- 97
- 125
- Tax %
- 22
- Net Profit
- 98
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 0
- Share of Associates
- -0
- Adjusted EPS
- —
- Minority Interest
- 0
- Share of Associates
- -0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 16%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 4%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- -10%
- 3 Years:
- -1%
- 1 Year:
- -33%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 8%
- Last Year:
- 9%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| LIABILITIES | - | - | - | - |
| Equity Capital | 16 | 16 | 16 | 16 |
| 667 | 720 | 791 | 860 | |
| 8 | 8 | 112 | 148 | |
| Trade Payables | 77 | 62 | 82 | 97 |
| 108 | 102 | 168 | 157 | |
| Total Liabilities | 875 | 909 | 1,170 | 1,278 |
| ASSETS | - | - | - | - |
| 386 | 471 | 647 | 670 | |
| Capital Work in Progress | 28 | 25 | 10 | 3 |
| 0 | 0 | 0 | 32 | |
| 9 | 25 | 36 | 29 | |
| 0 | 0 | 176 | 278 | |
| Cash & Bank | 242 | 109 | 175 | 68 |
| 210 | 278 | 126 | 198 | |
| Total Assets | 875 | 909 | 1,170 | 1,278 |
| Total Debt | 41 | 32 | 160 | 204 |
| Net Working Capital | 213 | 124 | 140 | 109 |
| Contingent Liabilities | 4 | 4 | 23 | 55 |
| Book Value per Share | 217.33 | 234.43 | 250.05 | 271.39 |
| Face Value | 5.00 | 5.00 | 5.00 | 5.00 |
| Total Debt | 41 | 32 | 160 | 204 |
| Net Working Capital | 213 | 124 | 140 | 109 |
| Contingent Liabilities | 4 | 4 | 23 | 55 |
| Book Value per Share | 217.33 | 234.43 | 250.05 | 271.39 |
| Face Value | 5.00 | 5.00 | 5.00 | 5.00 |
Mar 2022
- Equity Capital
- 16
- 667
- 8
- Trade Payables
- 77
- 108
- Total Liabilities
- 875
- 386
- Capital Work in Progress
- 28
- 0
- 9
- 0
- Cash & Bank
- 242
- 210
- Total Assets
- 875
- Total Debt
- 41
- Net Working Capital
- 213
- Contingent Liabilities
- 4
- Book Value per Share
- 217.33
- Face Value
- 5.00
- Total Debt
- 41
- Net Working Capital
- 213
- Contingent Liabilities
- 4
- Book Value per Share
- 217.33
- Face Value
- 5.00
Mar 2023
- Equity Capital
- 16
- 720
- 8
- Trade Payables
- 62
- 102
- Total Liabilities
- 909
- 471
- Capital Work in Progress
- 25
- 0
- 25
- 0
- Cash & Bank
- 109
- 278
- Total Assets
- 909
- Total Debt
- 32
- Net Working Capital
- 124
- Contingent Liabilities
- 4
- Book Value per Share
- 234.43
- Face Value
- 5.00
- Total Debt
- 32
- Net Working Capital
- 124
- Contingent Liabilities
- 4
- Book Value per Share
- 234.43
- Face Value
- 5.00
Mar 2024
- Equity Capital
- 16
- 791
- 112
- Trade Payables
- 82
- 168
- Total Liabilities
- 1,170
- 647
- Capital Work in Progress
- 10
- 0
- 36
- 176
- Cash & Bank
- 175
- 126
- Total Assets
- 1,170
- Total Debt
- 160
- Net Working Capital
- 140
- Contingent Liabilities
- 23
- Book Value per Share
- 250.05
- Face Value
- 5.00
- Total Debt
- 160
- Net Working Capital
- 140
- Contingent Liabilities
- 23
- Book Value per Share
- 250.05
- Face Value
- 5.00
Mar 2025
- Equity Capital
- 16
- 860
- 148
- Trade Payables
- 97
- 157
- Total Liabilities
- 1,278
- 670
- Capital Work in Progress
- 3
- 32
- 29
- 278
- Cash & Bank
- 68
- 198
- Total Assets
- 1,278
- Total Debt
- 204
- Net Working Capital
- 109
- Contingent Liabilities
- 55
- Book Value per Share
- 271.39
- Face Value
- 5.00
- Total Debt
- 204
- Net Working Capital
- 109
- Contingent Liabilities
- 55
- Book Value per Share
- 271.39
- Face Value
- 5.00
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| 128 | 76 | 24 | 87 | |
| Cash from Investing | -241 | -109 | -129 | -100 |
| Cash from Financing | 176 | -33 | 84 | 14 |
| 64 | -66 | -20 | 1 | |
| Free Cash Flow | 128 | -56 | -207 | -3 |
| OCF / Net Profit | 1.88 | 1.23 | 0.43 | 1.13 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 |
| OCF / Net Profit | 1.88 | 1.23 | 0.43 | 1.13 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 |
Mar 2022
- 128
- Cash from Investing
- -241
- Cash from Financing
- 176
- 64
- Free Cash Flow
- 128
- OCF / Net Profit
- 1.88
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.88
- Cumulative 5-Year FCF
- 0
Mar 2023
- 76
- Cash from Investing
- -109
- Cash from Financing
- -33
- -66
- Free Cash Flow
- -56
- OCF / Net Profit
- 1.23
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.23
- Cumulative 5-Year FCF
- 0
Mar 2024
- 24
- Cash from Investing
- -129
- Cash from Financing
- 84
- -20
- Free Cash Flow
- -207
- OCF / Net Profit
- 0.43
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.43
- Cumulative 5-Year FCF
- 0
Mar 2025
- 87
- Cash from Investing
- -100
- Cash from Financing
- 14
- 1
- Free Cash Flow
- -3
- OCF / Net Profit
- 1.13
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.13
- Cumulative 5-Year FCF
- 0
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| PER SHARE | - | - | - | - |
| EPS (₹) | 21.78 | 19.78 | 17.60 | 24.03 |
| Book Value (₹) | 217.33 | 234.43 | 250.05 | 271.39 |
| Dividend per Share (₹) | 2.50 | 2.75 | 2.50 | 2.75 |
| Cash EPS (₹) | 34.96 | 36.91 | 40.69 | 51.39 |
| PROFITABILITY | - | - | - | - |
| Operating Margin % | 32.14% | 29.09% | 23.28% | 26.51% |
| Net Margin % | 15.02% | 12.75% | 9.17% | 10.82% |
| ROE % | 10.02% | 8.76% | 7.36% | 9.22% |
| ROCE % | 14.47% | 11.75% | 9.94% | 12.39% |
| 7.81% | 6.96% | 5.47% | 6.34% | |
| EFFICIENCY | - | - | - | - |
| Debtor Days | 46 | 49 | 73 | 116 |
| Inventory Days | 7 | 13 | 18 | 17 |
| Payable Days | 468 | 343 | 187 | 193 |
| -414 | -281 | -96 | -61 | |
| FINANCIAL HEALTH | - | - | - | - |
| Debt to Equity (x) | 0.06x | 0.04x | 0.20x | 0.23x |
| Interest Coverage (x) | 5.68x | 11.42x | 5.25x | 5.17x |
| 2.76x | 2.25x | 1.50x | 1.36x | |
| GROWTH | - | - | - | - |
| Revenue Growth % | 0.00% | 6.95% | 27.20% | 15.74% |
| Operating Profit Growth % | 0.00% | -3.22% | 13.67% | 33.92% |
| Net Profit Growth % | 0.00% | -9.18% | -8.49% | 36.54% |
| 0.00% | 0.00% | -11.02% | 36.55% | |
| VALUATION | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 34.93x | 32.68x |
| P/B (x) | 0.00x | 0.00x | 2.46x | 2.89x |
| Dividend Yield % | 0.00% | 0.00% | 0.41% | 0.35% |
| 0.00x | 0.00x | 12.23x | 12.39x |
Mar 2022
- EPS (₹)
- 21.78
- Book Value (₹)
- 217.33
- Dividend per Share (₹)
- 2.50
- Cash EPS (₹)
- 34.96
- Operating Margin %
- 32.14%
- Net Margin %
- 15.02%
- ROE %
- 10.02%
- ROCE %
- 14.47%
- 7.81%
- Debtor Days
- 46
- Inventory Days
- 7
- Payable Days
- 468
- -414
- Debt to Equity (x)
- 0.06x
- Interest Coverage (x)
- 5.68x
- 2.76x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 19.78
- Book Value (₹)
- 234.43
- Dividend per Share (₹)
- 2.75
- Cash EPS (₹)
- 36.91
- Operating Margin %
- 29.09%
- Net Margin %
- 12.75%
- ROE %
- 8.76%
- ROCE %
- 11.75%
- 6.96%
- Debtor Days
- 49
- Inventory Days
- 13
- Payable Days
- 343
- -281
- Debt to Equity (x)
- 0.04x
- Interest Coverage (x)
- 11.42x
- 2.25x
- Revenue Growth %
- 6.95%
- Operating Profit Growth %
- -3.22%
- Net Profit Growth %
- -9.18%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 17.60
- Book Value (₹)
- 250.05
- Dividend per Share (₹)
- 2.50
- Cash EPS (₹)
- 40.69
- Operating Margin %
- 23.28%
- Net Margin %
- 9.17%
- ROE %
- 7.36%
- ROCE %
- 9.94%
- 5.47%
- Debtor Days
- 73
- Inventory Days
- 18
- Payable Days
- 187
- -96
- Debt to Equity (x)
- 0.20x
- Interest Coverage (x)
- 5.25x
- 1.50x
- Revenue Growth %
- 27.20%
- Operating Profit Growth %
- 13.67%
- Net Profit Growth %
- -8.49%
- -11.02%
- P/E (x)
- 34.93x
- P/B (x)
- 2.46x
- Dividend Yield %
- 0.41%
- 12.23x
Mar 2025
- EPS (₹)
- 24.03
- Book Value (₹)
- 271.39
- Dividend per Share (₹)
- 2.75
- Cash EPS (₹)
- 51.39
- Operating Margin %
- 26.51%
- Net Margin %
- 10.82%
- ROE %
- 9.22%
- ROCE %
- 12.39%
- 6.34%
- Debtor Days
- 116
- Inventory Days
- 17
- Payable Days
- 193
- -61
- Debt to Equity (x)
- 0.23x
- Interest Coverage (x)
- 5.17x
- 1.36x
- Revenue Growth %
- 15.74%
- Operating Profit Growth %
- 33.92%
- Net Profit Growth %
- 36.54%
- 36.55%
- P/E (x)
- 32.68x
- P/B (x)
- 2.89x
- Dividend Yield %
- 0.35%
- 12.39x
Documents
Announcements
- General Updates
2026-08-20 - Krsnaa Diagnostics Limited has informed the Exchange about General Updates
- Analysts/Institutional Investor Meet/Con. Call Updates
2026-08-19 - Krsnaa Diagnostics Limited has informed the Exchange about Transcript
Annual Reports
Credit Ratings
- Credit Rating
2026-06-29 - Krsnaa Diagnostics Limited has informed the Exchange about Credit Rating
Concalls
Aug 2026
May 2026
Feb 2026